# Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)

> **NCT00093912** · PHASE3 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 739 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** clevidipine
- **DRUG:** sodium nitroprusside

## Key facts

- **NCT ID:** NCT00093912
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2006-10
- **Final completion:** 2006-11
- **Target enrollment:** 739 (ACTUAL)
- **Last updated:** 2014-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00093912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00093912, "Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00093912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*